Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation.
Ostrowska B, Szymczyk A, Olszewska-Szopa M, Romejko-Jarosińska J, Domańska-Czyż K, Dąbrowska-Iwanicka A, Tomczak W, Rybski S, Hus M, Wróbel T, Walewski J. Ostrowska B, et al. Among authors: dabrowska iwanicka a. Leuk Lymphoma. 2021 Dec;62(12):3031-3034. doi: 10.1080/10428194.2021.1941926. Epub 2021 Jun 23. Leuk Lymphoma. 2021. PMID: 34159888 No abstract available.
Primary mediastinal large B-cell lymphoma.
Dabrowska-Iwanicka A, Walewski JA. Dabrowska-Iwanicka A, et al. Curr Hematol Malig Rep. 2014 Sep;9(3):273-83. doi: 10.1007/s11899-014-0219-0. Curr Hematol Malig Rep. 2014. PMID: 24952250 Free PMC article.
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski J, Paszkiewicz-Kozik E, Michalski W, Rymkiewicz G, Szpila T, Butrym A, Giza A, Zaucha JM, Kalinka-Warzocha E, Wieczorkiewicz A, Zimowska-Curyło D, Knopińska-Posłuszny W, Tyczyńska A, Romejko-Jarosińska J, Dąbrowska-Iwanicka A, Gruszecka B, Jamrozek-Jedlińska M, Borawska A, Hołda W, Porowska A, Romanowicz A, Hellmann A, Stella-Hołowiecka B, Deptała A, Jurczak W. Walewski J, et al. Among authors: dabrowska iwanicka a. Br J Haematol. 2020 Mar;188(6):898-906. doi: 10.1111/bjh.16264. Epub 2019 Dec 2. Br J Haematol. 2020. PMID: 31792945 Free PMC article. Clinical Trial.
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Paszkiewicz-Kozik E, Michalski W, Taszner M, Mordak-Domagała M, Romejko-Jarosińska J, Knopińska-Posłuszny W, Najda J, Borawska A, Chełstowska M, Świerkowska M, Dąbrowska-Iwanicka A, Malenda A, Druzd-Sitek A, Konecki R, Kumiega B, Osowiecki M, Ostrowska B, Szpila T, Szymański M, Targoński Ł, Domańska-Czyż K, Popławska L, Giebel S, Lange A, Pluta A, Zaucha JM, Rymkiewicz G, Walewski J. Paszkiewicz-Kozik E, et al. Among authors: dabrowska iwanicka a. Br J Haematol. 2022 Jul;198(1):73-81. doi: 10.1111/bjh.18166. Epub 2022 Apr 1. Br J Haematol. 2022. PMID: 35362096 Free PMC article.
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.
Romejko-Jarosinska J, Ostrowska B, Dabrowska-Iwanicka A, Domanska-Czyz K, Rymkiewicz G, Paszkiewicz-Kozik E, Konecki R, Borawska A, Druzd-Sitek A, Lampka E, Osiadacz W, Osowiecki M, Popławska L, Swierkowska M, Targonski L, Tajer J, Lapinska G, Smorczewska M, Walewski J. Romejko-Jarosinska J, et al. Among authors: dabrowska iwanicka a. Sci Rep. 2022 Jun 22;12(1):10551. doi: 10.1038/s41598-022-14067-3. Sci Rep. 2022. PMID: 35732790 Free PMC article.
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience.
Ostrowska B, Domanska-Czyz K, Romejko-Jarosinska J, Osowiecki M, Targonski L, Poplawska L, Konecki R, Kotarska M, Szymanski M, Borawska A, Swierkowska M, Dabrowska-Iwanicka A, Druzd-Sitek A, Paszkiewicz-Kozik E, Mroz-Zycinska E, Tajer J, Wojciechowska-Lampka E, Osiadacz W, Rymkiewicz G, Lapinska G, Wojewodzka-Mirocha M, Michalski W, Walewski J. Ostrowska B, et al. Among authors: dabrowska iwanicka a. Br J Haematol. 2023 May;201(4):663-672. doi: 10.1111/bjh.18687. Epub 2023 Feb 10. Br J Haematol. 2023. PMID: 36762710
Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience.
Basak GW, Knopinska-Posluszny W, Matuszak M, Kisiel E, Hawrylecka D, Szmigielska-Kaplon A, Urbaniak-Kujda D, Dybko J, Zielinska P, Dabrowska-Iwanicka A, Werkun J, Rzepecki P, Wroblewska W, Wiktor-Jedrzejczak W. Basak GW, et al. Ann Hematol. 2011 May;90(5):557-68. doi: 10.1007/s00277-010-1098-7. Epub 2010 Oct 12. Ann Hematol. 2011. PMID: 20938660 Free PMC article.
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
Winiarska M, Bojarczuk K, Pyrzynska B, Bil J, Siernicka M, Dwojak M, Bobrowicz M, Miazek N, Zapala P, Zagozdzon A, Krol M, Syta A, Podszywalow-Bartnicka P, Pilch Z, Dabrowska-Iwanicka A, Juszczynski P, Efremov DG, Slabicki M, Zenz T, Le Roy A, Olive D, Rygiel TP, Leusen JH, Golab J. Winiarska M, et al. Among authors: dabrowska iwanicka a. MAbs. 2014;6(5):1300-13. doi: 10.4161/mabs.32106. Epub 2014 Oct 30. MAbs. 2014. PMID: 25517315 Free PMC article.
17 results